Quality control is one of the most important parts of pharmacy compounding because compounded medications are prepared for specific patient or clinical needs rather than manufactured as mass-market products. A reliable compounding pharmacy uses controlled procedures for ingredient sourcing, preparation, testing, documentation, storage, and dispensing to help maintain the quality and consistency of each formulation.
For clinics and healthcare providers, understanding these processes can make it easier to evaluate a compounding pharmacy and choose a pharmacy partner that follows appropriate professional and regulatory standards.
What Does Quality Control Mean in Pharmacy Compounding?
Quality control in compounding involves a series of checks designed to verify the identity, strength, purity, consistency, and appropriate handling of compounded medications. These controls can apply throughout the process, from receiving pharmaceutical ingredients to preparing, packaging, labeling, and releasing the finished formulation.
USP standards play an important role in pharmacy compounding. USP identifies standards for both nonsterile preparations and sterile preparations, with requirements intended to support consistency and quality in compounded medications.
A strong quality-control program may include:
- Ingredient verification and documentation
- Appropriate storage conditions
- Accurate weighing and measurement
- Equipment checks and calibration
- Environmental monitoring
- Personnel training
- Preparation and labeling procedures
- Quality testing when applicable
- Documentation and recordkeeping
These controls create multiple checkpoints rather than relying on a single final inspection.
Contact us
How Pharmacies Control the Quality of Ingredients
Quality control starts before a medication is compounded. Pharmacies need reliable sources for active pharmaceutical ingredients and excipients and should verify that materials meet applicable requirements.
The FDA specifically advises compounders to understand their bulk drug substance and excipient suppliers because the quality of these materials can directly affect the quality of compounded medications.
For pharmacies operating under Section 503A, FDA states that bulk drug substances must meet specific conditions, such as complying with an applicable USP or NF monograph when one exists, being a component of an FDA-approved drug when applicable, or appearing on the applicable FDA bulk drug list.
This makes supplier qualification an important part of the quality-control process.
Quality Control for Sterile Compounding
Sterile compounding requires additional controls because contamination can create significant risks when medications are administered through sterile routes.
USP standards for sterile compounding address areas such as controlled environments, personnel competency, aseptic practices, and testing. For example, USP materials describe requirements involving media-fill testing and competency assessments for personnel performing sterile compounding.
For a deeper explanation of the process, see Emerald’s guide to sterile compounding pharmacy.
Quality controls may include:
- Controlled compounding environments
- Appropriate personal protective equipment
- Aseptic technique
- Environmental monitoring
- Personnel competency testing
- Sterility-related testing when required
- Proper storage and beyond-use dating procedures
These safeguards help reduce the risk of contamination and preparation errors.
Quality Control for Non-Sterile Compounding
Non-sterile preparations follow a different set of controls because they do not require the same sterile environment as injectable or other sterile products.
Quality control can involve accurate ingredient measurement, appropriate equipment, proper preparation techniques, appropriate packaging, labeling, and documentation. USP identifies <795> Pharmaceutical Compounding—Nonsterile Preparations as the standard addressing nonsterile compounding practices.
Emerald also provides information about non-sterile compounding and how these preparations can support customized medication needs.
Contact us
How Personnel Training Supports Quality
Even the best equipment cannot replace properly trained personnel. Pharmacists and compounding staff need appropriate education and competency assessments for the types of preparations they handle.
Training can cover:
- Accurate calculations and measurements
- Ingredient handling
- Equipment operation
- Cleaning procedures
- Aseptic technique where applicable
- Documentation
- Quality-control procedures
- Identification and management of preparation errors
For sterile compounding in particular, USP materials describe competency assessments and recurring evaluations for personnel performing aseptic manipulations.
Consistent training helps make quality control part of the everyday workflow rather than something performed only after a problem occurs.
How Documentation Helps Maintain Consistency
Documentation provides a record of how a compounded medication was prepared and helps pharmacies investigate problems when necessary.
Depending on the formulation and applicable requirements, records may include:
- Ingredient information
- Lot numbers
- Expiration dates
- Calculations
- Preparation instructions
- Personnel involved
- Equipment information
- Quality-control checks
- Final product information
Accurate documentation also creates traceability throughout the compounding process.
How Quality Control Differs Between 503A and 503B
The regulatory framework matters when evaluating a compounding pharmacy because 503A pharmacies and 503B outsourcing facilities operate under different requirements.
Under Section 503A, compounding is generally performed by a licensed pharmacist in a state-licensed pharmacy or by a licensed physician and is generally based on a valid prescription for an identified patient. Under Section 503B, outsourcing facilities are registered with the FDA and are subject to current good manufacturing practice requirements.
| 503A Pharmacy | 503B Outsourcing Facility |
| Typically patient-specific compounding | May compound without patient-specific prescriptions |
| Operates under applicable pharmacy requirements | Registered with FDA as an outsourcing facility |
| Generally overseen primarily by state pharmacy regulators | Primarily overseen and inspected by FDA |
| Not subject to CGMP requirements under the 503A exemption | Subject to CGMP requirements |
Understanding this distinction helps healthcare practices ask more informed questions when evaluating pharmacy partners.
Contact us
What Should Clinics Look for in a Compounding Pharmacy?
Healthcare practices should evaluate more than price or turnaround time when selecting a compounding pharmacy. Quality systems, regulatory compliance, communication, documentation, and the pharmacy’s ability to support the practice’s specific needs should all be considered.
Important questions include:
- What type of compounding does the pharmacy perform?
- What quality-control procedures are used?
- How are ingredients sourced and verified?
- How are personnel trained?
- What documentation is provided?
- How are complaints or quality concerns handled?
- What regulatory framework applies to the pharmacy?
- Does the pharmacy have experience supporting the type of practice being served?
Emerald’s resource on how to choose a compounding pharmacy provides additional considerations for evaluating a pharmacy.
Why Quality Control Matters for Medical Practices
For physicians, dermatology practices, wellness clinics, and other healthcare organizations, consistent pharmacy processes can make coordination easier. A pharmacy partner may need to handle customized formulations, communicate clearly with providers, and maintain appropriate documentation throughout the process.
This becomes especially relevant when practices use customized medication solutions rather than relying exclusively on commercially available formulations.
Emerald explains how custom medication solutions for medical practices can support practices that require individualized compounding services.
Quality Control Is an Ongoing Process
Quality control does not end when a compounded medication leaves the compounding area. It is an ongoing system that includes ingredient management, staff competency, environmental controls, preparation procedures, documentation, storage, and continuous evaluation.
FDA emphasizes that compounded medications must comply with applicable legal and regulatory requirements, while pharmacies and outsourcing facilities may operate under different quality standards depending on their regulatory status.
For healthcare practices, the key is to work with a pharmacy that can clearly explain its quality systems and demonstrate how those systems are integrated into daily compounding operations.
Conclusion
A reliable compounding pharmacy quality control program is built around multiple layers of verification rather than a single quality check. Ingredient sourcing, trained personnel, controlled preparation environments, accurate documentation, appropriate testing, and regulatory compliance all contribute to the overall quality of compounded medications.
For clinics considering a compounding pharmacy partner, asking detailed questions about these processes can provide a clearer picture of how the pharmacy manages quality from the beginning of the compounding process through final dispensing.
Contact us
FAQs
Is quality control required for compounded medications?
Yes. Compounding pharmacies must follow applicable federal, state, and professional requirements. The specific requirements depend on the type of compounder and the regulatory framework under which it operates.
Are sterile and non-sterile compounding quality controls the same?
No. Sterile preparations require additional controls designed to minimize microbial contamination and maintain sterility. Non-sterile preparations follow different standards and procedures.
How does a pharmacy verify its ingredients?
Pharmacies may review supplier information, certificates of analysis, lot information, applicable standards, and other documentation. FDA specifically encourages compounders to understand their bulk drug substance and excipient suppliers.
Are 503A pharmacies subject to the same requirements as 503B facilities?
No. 503A and 503B compounders operate under different federal frameworks. 503B outsourcing facilities are subject to CGMP requirements, while qualifying 503A compounding is exempt from certain federal requirements, including CGMP, under the conditions established by Section 503A.
What should a medical practice ask before choosing a compounding pharmacy?
Practices should ask about ingredient sourcing, quality-control procedures, personnel training, documentation, regulatory status, preparation capabilities, and how the pharmacy handles quality concerns or recalls.
